|Fiscal Impact Statement: SB711F122.PDF 2022-02-01|
|Name||Amanda F. Chase|
|Name||R Amanda Freeman Chase|
Prescriptions; off-label use. Provides thata licensed health care provider with prescriptive authority may prescribe,administer, or dispense a drug that has been approved for a specificuse by the U.S. Food and Drug Administration for an off-label usewhen the health care provider determines, in his professional judgment,that such off-label use is appropriate for the care and treatmentof the patient and prohibits a pharmacist from refusing to dispensea drug for off-label use if a valid prescription is presented.
Passed by indefinitely in Education and Health (9-Y 6-N)
Senate committee, floor amendments and substitutes offered
Impact statement from DPB (SB711)
Assigned Education sub: Health Professions
Referred to Committee on Education and Health
Presented and ordered printed 22104615D
No votes recorded on SB 711.